Prevention and Restoration of Hearing Loss Associated with the Use of Cisplatin

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Trial title</td><td align="center">Trial status</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Protection from cisplatin ototoxicity by lactated Ringers</td><td align="center">Completed</td></tr><tr><td align="left">Alpha-Lipoic acid in preventing hearing loss in cancer patients undergoing treatment with cisplatin</td><td align="center">Completed</td></tr><tr><td align="left">The protective effect of Ginkgo Biloba extract on cisplatin-induced ototoxicity in humans</td><td align="center">Completed</td></tr><tr><td align="left">Preventing nephrotoxicity and ototoxicity from osteosarcoma therapy</td><td align="center">Recruiting</td></tr><tr><td align="left">Sodium thiosulfate in preventing hearing loss in young patients receiving cisplatin for newly diagnosed germ cell tumor, hepatoblastoma, medulloblastoma, neuroblastoma, osteosarcoma, or other malignancies</td><td align="center">Active, not recruiting</td></tr><tr><td align="left">SPI-1005 for prevention and treatment of chemotherapy induced hearing loss</td><td align="center">Not yet recruiting</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Clinical trials currently underway (<a href="http://clinicaltrials.gov/ct2/results?term=cisplatin+ototoxicity" target="_blank">http://clinicaltrials.gov/ct2/results?term=cisplatin+ototoxicity</a>).

BioMed Research International

tab3

Table 3

Table 3: Prevention and Restoration of Hearing Loss Associated with the Use of Cisplatin 